Modern insulin pumps are self-contained devices that attach to a user’s skin via an adhesive patch, and are responsible ... [Ido Roseman] tore down an Omnipod Dash and took some pictures showing ...

Insulin pumps are ... have taken the form of a patch with a pump mounted directly upon it. When [Pete Schwamb]’s daughter received one of these pumps, an Omnipod, he responded to a bounty ...

Embecta received FDA clearance for its insulin patch pump in September ... with Insulet receiving FDA clearance for its Omnipod 5 patch pump for Type 2 diabetes in August. After Embecta received ...

Omnipod 5, performed better than conventional insulin pumps in a clinical trial for patients with type 1 diabetes. Its OP5-003 trial, conducted in the U.S. and France for adults with type 1 ...

Insulet's Omnipod The deal has been axed a few weeks after a federal judge in the US blocked EOFlow from selling its insulin patch pump in a lawsuit brought by Insulet, which sells a rival product.

The lawsuit revolved around Insulet's Omnipod tubeless insulin pump ... a federal judge blocked EOFlow from selling its insulin patch pump in the US. Medtronic said its decision to walk ...

claiming EOFlow copied patented components of its Omnipod insulin pumps. Insulet has dominated the U.S. market for insulin patch pumps: small, wearable devices intended to replace daily insulin ...

Its lawsuit said EOFlow hired away former Insulet employees to develop its EOPatch, an insulin device similar to Insulet's Omnipod. After failing for six years to design its own patch pump ...

There has been no shortage of news covered across the diabetes and drug delivery markets over the course of 2024.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced that it has successfully defended ...